Kingfisher Soars, Roche's Shot, Ericsson's Slip

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Kingfisher shares rise as much as 11%, the most in a year, after the B&Q and Screwfix owner posted a first-half earnings beat and lifted its full-year profit guidance beyond analyst expectations.
- Roche Holding’s experimental obesity shot enicepatide cut both blood sugar and body weight in type-2 diabetes patients who were overweight or obese in a mid-stage trial.
- Ericsson slips as much as 3.9%, the most since mid July, after Morgan Stanley downgrades the Swedish mobile networks and technology group to underweight from equal-weight, saying margins are “inflecting to the downside.”

See omnystudio.com/listener for privacy information.